Literature DB >> 25575057

[miR-25 promotes cell proliferation by targeting RECK in human cervical carcinoma HeLa cells].

Gang Qiu1, Baoshuan Fang1, Guohong Xin2, Qiang Wei3, Xiaoye Yuan4, Dayong Wu3.   

Abstract

OBJECTIVE: To investigate the effect of miR-25 on the proliferation of human cervical carcinoma HeLa cells and its association with reversion-inducing cysteine-rich protein with Kazal motifs (RECK).
METHODS: The recombinant plasmids of pcDNATM6.2-GW-pre-miR-25, pmirGLO-RECK-WT, pmirGLO-RECK-MT and anti-miR-25 were constructed, and their transfection efficiencies into HeLa cells were identified by real-time quantitative PCR (qRT-PCR). The potential proliferation-stimulating function of miR-25 was analyzed by MTT assay in HeLa cells. Furthermore, the target effect of miR-25 on the RECK was determined by dual-luciferase reporter assay system, qRT-PCR and Western blotting.
RESULTS: Sequence analysis demonstrated that the recombinant plasmids of pcDNATM6.2-GW-pre-miR-25 and pmirGLO-RECK-WT, pmirGLO-RECK-MT were successfully constructed, and qRT-PCR revealed that the transfection efficiencies of pre-miR-25 and anti-miR-25 were desirable in HeLa cells. MTT assay showed that miR-25 over-expression promoted the proliferation of HeLa cells. In addition, the luciferase activity was significantly reduced in HeLa cells cotransfected with pre-miR-25 and RECK-WT. The qRT-PCR and Western blotting indicated that the expression level of RECK was up-regulated in HeLa cells transfected with anti-miR-25 at the transcriptional and posttranscriptional levels.
CONCLUSION: miR-25 could promote cell proliferation by targeting RECK in HeLa cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25575057

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  1 in total

1.  MiR-21-5p promotes the progression of non-small-cell lung cancer by regulating the expression of SMAD7.

Authors:  Xiangpan Li; Xiaofei Wu
Journal:  Onco Targets Ther       Date:  2018-11-28       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.